The Street Reports Weekly Flashback - Pennystocks Captain Pennys Open House
investorshangout.com/post/view?id...
#RIME #DRK #VIVS #GMG #AMFN #CFTN #AMLM #GRLF

#VIVS $VIVS VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods

www.globenewswire.com/news-release...

#VIVS VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods

https://www.stocktitan.net/news/VIVS/vivo-sim-labs-celebrates-updated-fda-regulations-allowing-greater-rm82mguiafxg.html?utm_source=stocktitan-bluesky&utm_medium=social

#VIVS The FDA’s push toward New Approach Methodologies (NAMs) could create an important opportunity for VivoSim Labs Inc. (NASDAQ: VIVS) and its NAMkind™ 3D human tissue platform, designed to identify drug toxicity earlier using human-relevant biology.
thestreetreports.com/vivosim-nasd...

#VIVS $VIVS VivoSim Labs (NASDAQ: VIVS) Targets Complex ADC Drug Toxicity With Human 3D Biology

thestreetreports.com/vivosim-labs...

#VIVS $VIVS VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs

thestreetreports.com/vivosim-labs...

From AI data centers and Alzheimer’s research to drug safety testing and humanoid robots, six small-cap companies are approaching developments that could shape their next phase of growth.
thestreetreports.com/2026-nanocap...
#IGC #GPUS #VIVS #ONGO #SUGP #FTHM

#VIVS $VIVS VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem

thestreetreports.com/vivosim-labs...

The Street Report Weekly Rewind 9/18
investorshangout.com/post/view?id...
#RIME #VIVS #DRK #KRTL #CFTN #GMG

#VIVS VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
www.globenewswire.com/news-release...

#VIVS $VIVS VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

www.globenewswire.com/news-release...

#VIVS $VIVS Catch the Danger, Spare the Cure: Why VivoSim’s (NASDAQ: VIVS) 90%/95% Toxicity Results Matter

thestreetreports.com/catch-the-da...

#VIVS Catch the Danger, Spare the Cure:
thestreetreports.com/catch-the-da...

$VIVS #VIVS VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials

thestreetreports.com/vivosim-labs...

#VIVS VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials
thestreetreports.com/vivosim-labs...